Nanocellulose-based Sustainable Solutions for Diverse Industries

Publication ID: 24-11857405_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Nanocellulose-based Sustainable Solutions for Diverse Industries,” Published Technical Disclosure No. 24-11857405_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857405_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,405.

Summary of the Inventive Concept

The present inventive concept leverages the core technology of the original medical implant patent to develop novel, eco-friendly applications in packaging, logistics, textiles, water filtration, and construction materials.

Background and Problem Solved

The original patent addressed the need for a medical implant for repairing bile ducts. However, the limitations of the original patent lie in its restricted application to the medical field. The present inventive concept tackles this limitation by exploring new, uncharted territories for the nanocellulose technology, providing sustainable solutions to various industries plagued by environmental concerns.

Detailed Description of the Inventive Concept

The inventive concept encompasses a range of novel applications, including biodegradable packaging containers, carbon footprint-reducing logistics materials, compostable textile fabrics, microbial cellulose-based water filtration systems, and sustainable construction materials. These applications capitalize on the unique properties of nanocellulose, such as its biodegradability, compostability, and porous structure. The production methods for these applications involve modifications to the original patent's method for producing microbial cellulose tubes, incorporating new materials and processing techniques.

Novelty and Inventive Step

The inventive concept's novelty lies in its extension of the original patent's technology to entirely new fields, unexplored in the original patent. The inventive step resides in the recognition of the potential of nanocellulose to address pressing environmental issues in diverse industries, and the development of innovative solutions to capitalize on this potential.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different microbial cellulose production methods, varying the composition of the nanocellulose-based materials, or incorporating additional features to enhance the performance of the applications. Variations could also involve adapting the nanocellulose technology to address specific challenges in each target industry.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the packaging, logistics, textiles, water filtration, and construction materials industries, where there is a growing demand for sustainable, eco-friendly solutions. The market for these applications is substantial, with opportunities for partnerships, collaborations, and licensing agreements.

CPC Classifications

SectionClassGroup
A A61 A61F2/04
A A61 A61L31/005
A A61 A61L31/10
A A61 A61L31/146
A A61 A61F2002/041
A A61 A61L2400/12
A A61 A61L2420/08
C C08 C08L1/02

Field of Art

Biomaterials and medical device engineering, with expertise in nanocellulose-based materials, microbial cellulose production techniques, and interdisciplinary material applications

Person of Ordinary Skill (PHOSITA) Profile

A researcher or engineer with advanced degrees in materials science, bioengineering, or chemical engineering, possessing knowledge of biomaterial fabrication, microbial cellulose synthesis, and cross-industry material adaptations

Obviousness Rationale

A PHOSITA would recognize that the fundamental microbial cellulose tube technology disclosed in the source patent inherently possesses versatile properties that enable adaptation across multiple industrial domains. The core production methodology involving concentric layering and template-based formation provides a flexible platform for material transformation. Given nanocellulose's well-established biodegradability and structural adaptability, extending the medical implant technology to packaging, filtration, and construction applications represents a predictable engineering progression.

Obvious Combinations & Variations

Source Patent Element
Microbial cellulose tube with concentric layers and defined wall structure
PTD Variation
Biodegradable packaging container utilizing identical microbial cellulose tube formation technique
Obviousness Reasoning
Predictable application of existing tube-formation method to create structural containers, representing a straightforward design adaptation with known material properties
Source Patent Element
Tubular stent-based expansion method for modifying microbial cellulose geometry
PTD Variation
Water filtration system leveraging porous structure created through controlled tube expansion
Obviousness Reasoning
Known technique of geometric manipulation applied to create engineered porosity, representing a standard materials science approach to developing functional structures
Source Patent Element
Microbial cellulose production using liquid culture medium and template molding
PTD Variation
Textile fabric production using modified fiber formation techniques
Obviousness Reasoning
Established material science principle of adapting production methodology across related material domains, utilizing fundamentally similar processing techniques
Source Patent Element
Nanocellulose tube with defined inner and outer surface characteristics
PTD Variation
Construction composite material combining microbial cellulose with binding agents
Obviousness Reasoning
Predictable material engineering approach of combining known substances to create enhanced composite materials with improved structural properties
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. § 103, the variations disclosed herein would have been obvious to a person having ordinary skill in the art at the time of invention, as evidenced by US Patent 11857405, with the present publication demonstrating that the fundamental microbial cellulose tube technology represents a versatile platform technology capable of straightforward adaptation across diverse industrial applications through routine engineering modifications.

Original Patent Information

Patent NumberUS 11,857,405
TitleMedical implant based on nanocellulose
Assignee(s)UNIVERSITÄTSKLINIKUM JENA